- Home
- EBS vs EMO Comparison
EBS vs EMO Comparison
Compare EBS & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- EMO
- Stock Information
- Founded
- EBS 1998
- EMO 2011
- Country
- EBS United States
- EMO United States
- Employees
- EBS N/A
- EMO N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- EBS Health Care
- EMO Finance
- Exchange
- EBS Nasdaq
- EMO Nasdaq
- Market Cap
- EBS 459.6M
- EMO 547.7M
- IPO Year
- EBS 2006
- EMO N/A
- Fundamental
- Price
- EBS $8.09
- EMO $45.00
- Analyst Decision
- EBS Strong Buy
- EMO
- Analyst Count
- EBS 2
- EMO 0
- Target Price
- EBS $14.00
- EMO N/A
- AVG Volume (30 Days)
- EBS 999.1K
- EMO 27.1K
- Earning Date
- EBS 11-06-2024
- EMO 01-01-0001
- Dividend Yield
- EBS N/A
- EMO 6.70%
- EPS Growth
- EBS N/A
- EMO N/A
- EPS
- EBS N/A
- EMO N/A
- Revenue
- EBS $1,125,500,000.00
- EMO N/A
- Revenue This Year
- EBS $6.64
- EMO N/A
- Revenue Next Year
- EBS $7.95
- EMO N/A
- P/E Ratio
- EBS N/A
- EMO N/A
- Revenue Growth
- EBS 2.05
- EMO N/A
- 52 Week Low
- EBS $1.42
- EMO $26.42
- 52 Week High
- EBS $15.10
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- EBS 39.08
- EMO 39.33
- Support Level
- EBS $8.35
- EMO $44.00
- Resistance Level
- EBS $8.86
- EMO $48.00
- Average True Range (ATR)
- EBS 0.50
- EMO 1.31
- MACD
- EBS -0.11
- EMO -0.59
- Stochastic Oscillator
- EBS 17.58
- EMO 16.81
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.